Clarivate PLC (CLVT) reported $617 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 6.9%. EPS of $0.20 for the same period compares to $0.21 a year ago.
The reported revenue represents a surprise of +2.35% over the Zacks Consensus Estimate of $602.86 million. With the consensus EPS estimate being $0.16, the EPS surprise was +25%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Clarivate performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- Life Sciences & Healthcare: $98.3 million versus the two-analyst average estimate of $102.02 million. The reported number represents a year-over-year change of -11.4%.
- Revenues- Academia & Government: $312.3 million compared to the $295.38 million average estimate based on two analysts. The reported number represents a change of -8.9% year over year.
- Revenues- Intellectual Property: $206.4 million versus the two-analyst average estimate of $205.1 million. The reported number represents a year-over-year change of -1.3%.
View all Key Company Metrics for Clarivate here>>>
Shares of Clarivate have returned -41.9% over the past month versus the Zacks S&P 500 composite's -1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Clarivate PLC (CLVT): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
